BioSpace News Archive

It’s a busy news day for COVID-19-related stories. Read on for more.

Seres Therapeutics and Nestlé Health Science have announced a decision to team up for the joint commercialization of Seres’s investigational oral microbiome treatment for recurrent Clostridioides difficile infections.

The vaccine, dubbed ZyCoV-D, will be the first DNA vaccine available in the world if authorized by regulators.

After the July 4 holiday, the U.S. FDA has several things on their immediate calendar, including a couple target action dates and an advisory committee hearing. Here’s a look.

Sheets of functionalized graphene quickly detected the SARS-CoV-2 virus in research conducted at the University of Illinois Chicago, paving the way for an alternative to PCR testing in the form of an accurate, real-time optical test for COVID-19.

Positive results from Sellas Life Sciences Group’s Phase I/II trial using galinpepimut-S (GPS) as a combination therapy with pembrolizumab (Keytruda®) were announced Wednesday, shortly after similarly positive news was issued from a combination study in which GPS was evaluated as a treatment for mesothelioma.

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Rising prevalence of chronic diseases across the globe, increasing investments in research and development activities and efforts taken by public and private sectors to support and fund neurological diseases are key factors boosting global market growth.

Jennifer Doudna is best known for discovering CRISPR/Cas9 gene editing with Emmanuelle Charpentier, and both winning the Nobel Prize in Chemistry in 2020.

If you’re questioning which types of leaders you get along with the best, or you’re just wondering what types of leaders exist, you’re in the right place. Here’s a quick breakdown.